-+ 0.00%
-+ 0.00%
-+ 0.00%
Does Ouster’s (OUST) Native Color Lidar Advance a Defensible Edge in Physical AI?
Share
Listen to the news
  • In May 2026, Ouster announced that industrial inspection specialist Gecko Robotics is using its new Rev8 digital lidar sensors to enhance 3D asset mapping, while the Rev8 family was also qualified for NVIDIA DRIVE Hyperion and incorporated Fujifilm’s color science to create native color lidar.
  • This combination of color-rich, structurally aligned 3D data and automotive-grade integration positions Ouster’s Rev8 sensors as a potential building block for more capable Physical AI and autonomous systems across industrial and transportation settings.
  • We’ll now assess how Ouster’s native color Rev8 lidar, built with Fujifilm and adopted by Gecko Robotics, may influence the company’s investment narrative.

Find 49 companies with promising cash flow potential yet trading below their fair value.

Ouster Investment Narrative Recap

To own Ouster, you need to believe lidar can become a core sensor for “Physical AI” across traffic systems, robotics, and autonomy, and that Ouster can convert its technology edge into durable customer programs. The Gecko Robotics win reinforces the near term catalyst around real world Rev8 adoption, but it does not remove the key risks: intense competition, high valuation, ongoing losses, and quarterly volatility tied to customer orders and product mix.

Among the recent announcements, Rev8’s qualification on NVIDIA DRIVE Hyperion looks most relevant. It puts Ouster’s new sensors directly into a major Level 4 development ecosystem, aligning with the same Physical AI story behind the Gecko partnership. For investors focused on catalysts, this pairing of industrial inspection and automotive integration highlights how quickly Rev8 could become a reference platform, while still leaving open questions around pricing pressure, margins, and how fast programs scale from pilots to production.

Yet beneath the product buzz, investors should also be aware that...

Read the full narrative on Ouster (it's free!)

Ouster's narrative projects $414.8 million revenue and $8.9 million earnings by 2029. This requires 34.8% yearly revenue growth and a $69.3 million earnings increase from -$60.4 million today.

Uncover how Ouster's forecasts yield a $39.67 fair value, a 7% upside to its current price.

Exploring Other Perspectives

OUST 1-Year Stock Price Chart
OUST 1-Year Stock Price Chart

The more cautious analysts remind you that even with Rev8 and partners like Gecko, they were only assuming about 32 percent annual revenue growth and no profits by 2029, so their view of contract risk and slower adoption could still reshape how this latest news is interpreted.

Explore 8 other fair value estimates on Ouster - why the stock might be worth less than half the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending